KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Total Liabilities (2016 - 2025)

Labcorp Holdings' Total Liabilities history spans 17 years, with the latest figure at $9.8 billion for Q4 2025.

  • For Q4 2025, Total Liabilities fell 5.4% year-over-year to $9.8 billion; the TTM value through Dec 2025 reached $9.8 billion, down 5.4%, while the annual FY2025 figure was $9.8 billion, 5.4% down from the prior year.
  • Total Liabilities for Q4 2025 was $9.8 billion at Labcorp Holdings, up from $9.6 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $10.4 billion in Q3 2024 and bottomed at -$10.7 billion in Q1 2022.
  • The 5-year median for Total Liabilities is $9.7 billion (2022), against an average of $6.8 billion.
  • The largest annual shift saw Total Liabilities tumbled 198.43% in 2021 before it soared 216.79% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $10.1 billion in 2021, then decreased by 0.51% to $10.0 billion in 2022, then dropped by 12.0% to $8.8 billion in 2023, then increased by 16.73% to $10.3 billion in 2024, then fell by 5.4% to $9.8 billion in 2025.
  • Per Business Quant, the three most recent readings for LH's Total Liabilities are $9.8 billion (Q4 2025), $9.6 billion (Q3 2025), and $9.6 billion (Q2 2025).